On 13 September 2011, a group of Stanford researchers convened an Obesity Summit under the title The Heterogeneity of Obesity: Implications for Prevention, Diagnosis and Treatment. The objective was to highlight the breadth and depth of obesity-related research that was being done on the Stanford campus across a broad range of disciplines. The disciplines represented included bariatric surgery, behavioral science, chemical and systems biology, community-based participatory research, epidemiology, endocrinology, health psychology, immunology, microbiology, nutrition, pathology, pediatrics, physical activity and psychiatry. The target audience was primarily the Stanford research community. The timing was scheduled to coincide with the preparation for a campus-wide initiative to apply to become an NIH/NIDDK Nutrition Obesity Research Center; an application that benefited from the discussions held and colleagues assembled at the Summit was successfully submitted in November 2011. Funding for the Summit was generously provided by the Nutrilite Health Institute, including sufficient support to publish the proceedings as a journal supplement. This is the context for the convening of the Summit and the subsequent publication of the individual presentations given.
After recruiting speakers broadly from across the many disciplines represented at Stanford, we deemed it practical to group the speakers into three main domains---a basic science perspective, a prevention/intervention perspective and a clinical perspective. A brief executive summary of these topics within each group follows.
BASIC SCIENCE PERSPECTIVE
The Summit began with several researchers providing a basic science perspective. Dr Edgar Engleman (Pathology) and colleagues recently discovered that B cells and the antibodies they produce are important contributors to the process whereby T cells and macrophages infiltrate visceral adipose tissue in obesity and orchestrate inflammation that contributes to insulin resistance. His presentation focused on the properties of these B cells and how they contribute to insulin resistance through T-cell modulation and production of pathogenic autoantibodies. This was followed by a presentation from Dr Tracey McLaughlin (Endocrinology), who reviewed several plausible hypotheses as to why some but not all individuals develop insulin resistance with weight excess. The hypotheses and mechanisms reviewed included regional fat distribution, inflammation, lipotoxicity/ectopic fat and impaired adipogenesis. Then, Dr Mary Teruel (Chemical and Systems Biology) provided a current overview of our understanding of the molecular mechanisms responsible for the conversion of preadipocytes to adipocytes, noting that a potential strategy that could have an impact on obesity prevention or treatment is to reduce this rate of conversion. This presentation included a discussion of several merging areas of basic science that are contributing to the advancement of this field of metabolism (this presentation was not available as a manuscript for the supplement). Overall, the topics presented in this first session of the Summit highlighted the metabolic heterogeneity of excess adiposity at the cellular and tissue levels, and suggested promising areas of future research.
PREVENTION/INTERVENTION PERSPECTIVE
The second session of the program included a group of obesity prevention researchers who provided their insights from an intervention perspective. Dr Gerald Reaven (Endocrinology) began the session with a Keynote lecture describing the complex relationships between obesity, insulin resistance and metabolic abnormalities (this presentation is not available as a manuscript for the supplement). Dr Christopher Gardner (Nutrition) then provided an overview of the past decade of weight-loss diet studies contrasting low-fat vs low-carbohydrate diets. He concluded that recent trials have consistently reported that lowcarbohydrate diets are as or more successful with weight loss and with several related metabolic parameters relative to low-fat diets, although an important qualifier to this conclusion is that the magnitude of average weight loss using either dietary approach is typically modest and usually disappointing. However, Dr Gardner also reported that the heterogeneity of weight loss response within any particular diet group is substantial, and that insulin resistance is likely one of the important factors that mediates the differential success that two individuals may have who are assigned to the same diet; individuals with greater insulin resistance are likely to be more successful on a low-carbohydrate diet compared with a low-fat diet, and the opposite may be true for overweight individuals who are more insulin sensitive. Dr Randall Stafford (Epidemiology) presented his perspectives on obesity prevention and intervention in the context of ongoing NIH-funded community-based participatory research in predominantly Hispanic communities in close proximity to Stanford. He and Dr Lisa Rosas contributed a manuscript to this supplement addressing the heterogeneity of obesity in advantaged vs disadvantaged populations (for example, racial, ethnic and socioeconomic status subgroups). They posit that research approaches to obesity developed in mainstream populations and deploying new information technologies are likely to unwittingly exacerbate existing disparities in obesity. They call for investigators to more explicitly focus on discovering innovative strategies for preventing and managing obesity in the disadvantaged populations that are most affected, and offer four key research approaches to address this call to action. Dr Michaela Kiernan (Health/Social Psychology) contributed to this supplement by addressing treatment matching for obesity and argues for the need to identify the mediators of psychosocial and behavioral intervention components used in tailored weight-loss programs. She notes that given the recent advances in genomics, neuroscience and other fields, both the breadth of domains and combinations of individuals' characteristics that could be used for treatment matching have increased markedly. However, she cautions that the success of treatment matching will rely on identifying treatment intervention components with well-differentiated and empirically supported mediators, that is, clear insights into how intervention components work. Dr Kiernan explores the opportunities and challenges of this field of investigation and offers suggestions for areas for future research. Dr Mary Rosenberger (Physical Activity) presented an intriguing paradigm shift in the area of physical activity and obesity. Rather than discussing strategies for increasing bouts of exercise, Dr Rosenberger reframed the topic area by discussing novel strategies for decreasing sedentary behaviors. An important component of her presentation was a discussion of the methodological challenges of accurately assessing sedentary activity. The discussion of these challenges was followed by potential solutions, as Dr Rosenberger and colleagues have been working for several years with collecting real-time data (for example, blue tooth technology, mobile phones) from multiple accelerometers worn on different parts of the body that can capture subtle but important changes in the levels of sedentary activity more accurately than the traditional single accelerometer warn on the hip. At the Summit, Dr C Barr Taylor (Psychiatry) presented pilot data from an internet-based weight-control tool being developed for high school populations. Although the exponential growth of Internet use has opened an entirely new set of opportunities to develop health promotion tools, Dr Taylor notes that the many challenges in adapting this for weight-loss strategies in high school populations include adapting them to local needs and interests while demonstrating effectiveness and salience for both universal and targeted populations. The preliminary results presented suggest that providing a universal and targeted online healthy weight regulation program to ninth grade students is feasible and inexpensive. As discussed later in this supplement, Dr Taylor and colleagues elaborate on the usefulness of the Internet program designed by his team serving as a 'core' for future studies, and emphasize the need for adaptive, continuous quality improvement designs. Overall, the prevention and intervention session of the Summit demonstrated the richness of different strategies to be drawn on for obesity prevention and treatment, the opportunities and responsibilities to target specific populations, the importance of identifying the key mediators of weight loss and the need for strong and validated methodologies to continue to move this field forward.
CLINICAL PERSPECTIVE
The final session of the program focused on a clinical perspective of the obesity epidemic, with presentations about the ongoing pediatric Healthy Weight clinic directed by Dr Thomas Robinson, the newly created Bariatric and Metabolic Interdisciplinary clinic directed by Dr John Morton and an update on plans to develop an adult weight-loss clinic at the Stanford University Hospital and Medical School. Several of the topics presented were common to all three clinics, such as the challenges of obtaining insurance coverage of services and a backlog of eligible patients. Other topics were unique and specific to the different target populations. Dr Robinson (Pediatrics) and colleagues started the Center for Healthy Weight at Stanford University and Lucile Packard Children's Hospital at Stanford in the early 2000s. It was organized based on specific strengths of Stanford's institutions, with a children's hospital, medical school and university all sharing the same campus. The design of the Center for Healthy Weight provides both breadth and depth through six cores: research, patient care, community programs, advocating for public policy change, training and professional education and the healthy hospital initiative. The Center and its cores are designed to facilitate interdisciplinary collaboration. The foci of these cores are likely to be relevant to almost any academic medical center's mission and functions. In his Summit presentation and in this supplement contribution, Dr Robinson and coauthor Karen Kemby elaborate on the development and growth of the Center, and they suggest that this is a model that may be replicated and/or adapted to many different settings, as many academic medical centers will have similar resources to draw upon. Two of the Summit presenters then provided complementary perspectives on the ongoing development of an adult weight-loss clinic at Stanford. The first of these two, Dr Neil Gesundheit, focused his talk at the Summit on the 'treatment gap' in clinical weight-loss programs, and the need to address this. As described later in this supplement, Dr Gesundheit notes that current weight-loss programs tend to fall into one of two baskets---the group of lifestyle interventions and drug therapies that typically lead to a modest average weight loss of 4--7% body weight, and the various types of surgical procedures that have been reported to achieve weight loss in the 15--50% range. Therefore, the treatment gap Dr Gesundheit refers to is the 7--15% range of weight loss. In his article, he explores possible ways by which the treatment gap may be filled in the future through the use of innovative approaches. This segues nicely into the presentation and article written by his colleague, Dr Maja Artandi (General Internal Medicine). Dr Artandi presents her case for the need for a multidisciplinary clinic in which specialists from different disciplines share their knowledge and participate in the treatment of obese patients in order to address the complex etiology and therapy for obesity. In this model, Dr Artandi suggests the patient would first have individual meetings with a physician, a registered dietitian, a behavioral therapist and a physical activity specialist. After these meetings, the providers would meet to discuss the best therapeutic approach for each patient; essentially, this would be a 'metabolism board', analogous to tumor boards that convene for patients with cancer. This would lead to consideration of several different treatment options available for the patients and the selection of the most viable weight-loss plan from these options. These would start with behavioral/lifestyle approaches, then move to pharmacological therapies and, when necessary, progress to the consideration of surgical procedures. An overview of the current state of surgical procedures in the treatment of obesity is presented in this supplement by Dr John Morton and his colleague Nayna Lodhia. They discuss the heterogeneity of bariatric surgery in the context of the three most popular bariatric surgeries---Roux-en-y gastric bypass, sleeve gastrectomy and gastric banding procedures---all of which are currently overwhelmingly performed laparoscopically. In their article, the authors provide data and comparisons among the three types of procedures for use, success with weight loss, impact on related comorbidities and metabolic variables, as well as complication rates. Morton and Lodhia conclude that despite variation in patient, surgeon and hospital characteristics, bariatric surgery outcomes are generally highly safe and effective, and that they are currently an underutilized treatment option for obesity. They also recommend that patients be educated about the diversity in outcomes in order to set realistic patient expectations. Overall, in the Summit's final set of presentations from the clinical perspective, it was clear that the existing and developing clinical models for obesity treatment are taking advantage of available evidence-based strategies while forging and incorporating new strategies as they become available.
CONCLUSIONS
Between the convening of the September 2011 Stanford Obesity Summit and the submission of these supplement materials, the latest CDC updates of obesity rates in America were published---B35% in adults 1 and 17% in children. 2 The trends suggest an overall plateau, but there are important differences, including continuing increases in subsets of underserved and disadvantaged populations.
1,2 Successful weight-loss strategies do exist, 3 but the elephant in the room is still the extremely high rate of recidivism and proportion who regain all the weight they lost and sometimes more 4, 5 (with a few notable exceptions 6 ). All in all, nationally and globally, current efforts in reversing the obesity epidemic have been grossly disappointing, and not for lack of effort, or research funding, or great minds working on this crisis. As limited as the return has been on the extensive investment to address this national and global crisis, throwing in the towel is not an option. Obesity is related to, and likely an underlying factor in, the majority of chronic diseases that are crippling our health-care system---cardiovascular, respiratory, gastrointestinal and musculoskeletal diseases, immune disorders, cancer and especially diabetes. We must continue to address and attack this crisis with innovative solutions using the types of multidisciplinary approaches that are a hallmark of Stanford University and other great research institutions. Looking back to the seminal study overfeeding twins by Bouchard and colleagues, 7 the high variability of weight gain in response to the same level of caloric overfeeding over the same period in time established early on that there is tremendous individual heterogeneity in the process of weight gain. We should expect no lesser level of individual heterogeneity in response to weight-loss strategies. Rather than being overwhelmed by that heterogeneity, and our inability to devise the one true and effective approach to weight-loss or weight-gain prevention, it appears that we will have to embrace that individual variability in the progression to obesity and in the response to prevention and treatment. The productive and dedicated investigators who assembled at the Stanford Obesity Summit and engaged their audience on these topics have all embraced this heterogeneity, and have been inspired and motivated by it. Collectively, we hope that the diverse perspectives offered in this supplement, representing the talks given at the 2011 Summit, will inspire and motivate others to dig deep with us into the heterogeneity of obesity and continue to hone our tools and increase the size of our tool chest so that together we can turn and reverse the tide of obesity and its debilitating individual and societal consequences.
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